For: | Spiliopoulou P, Arkenau HT. Rationally designed treatment for metastatic colorectal cancer: Current drug development strategies. World J Gastroenterol 2014; 20(30): 10288-10295 [PMID: 25132745 DOI: 10.3748/wjg.v20.i30.10288] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i30/10288.htm |
Number | Citing Articles |
1 |
Ping Zhao, Jacob Hall, Mary Durston, Austin Voydanoff, Elizabeth VanSickle, Shannon Kelly, Abhinav B Nagulapally, Jeffery Bond, Giselle Saulnier Sholler, Aamir Ahmad. BKM120 induces apoptosis and inhibits tumor growth in medulloblastoma. PLOS ONE 2017; 12(6): e0179948 doi: 10.1371/journal.pone.0179948
|
2 |
I. Kiss, J. Mlčochová, K. Součková, P. Fabian, A. Poprach, J. Halamkova, M. Svoboda, R. Vyzula, O. Slaby. MicroRNAs as outcome predictors in patients with metastatic colorectal cancer treated with bevacizumab in combination with FOLFOX. Oncology Letters 2017; 14(1): 743 doi: 10.3892/ol.2017.6255
|
3 |
Sayan Saha, Shreya Ghosh, Suman Ghosh, Sumit Nandi, Aditi Nayak. Unraveling the complexities of colorectal cancer and its promising therapies – An updated review. International Immunopharmacology 2024; 143: 113325 doi: 10.1016/j.intimp.2024.113325
|